Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lippman

Showing results (231-240 of 551) with videos related to

Pageof 56
Sort By:
Gene|March 7, 2006
Identification and characterization of the human retinoid X receptor alpha gene promoterGuojun Li, Weihong Yin, Robert Chamberlain, et al.
Breast Cancer Research and Treatment|May 1, 1988
Comparison of monoclonal antibodies for the detection of occult breast carcinoma metastases in bone marrowA Thor, M J Viglione, N Ohuchi, et al.
Plos One|July 5, 2013
MicroRNA profiling of salivary adenoid cystic carcinoma: association of miR-17-92 upregulation with poor outcomeYoshitsugu Mitani, Dianna B Roberts, Hanadi Fatani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1983
Influence of tumor estrogen and progesterone receptor levels on the response to tamoxifen and chemotherapy in primary breast cancerB Fisher, C Redmond, A Brown, et al.
Cancer Research|February 5, 2013
MicroRNA-related genetic variants associated with clinical outcomes in early-stage non-small cell lung cancer patientsXia Pu, Jack A Roth, Michelle A T Hildebrandt, et al.
The Oncologist|September 19, 2020
Attrition of Patients on a Precision Oncology Trial: Analysis of the I-PREDICT ExperienceSandy S Bohan, Jason K Sicklick, Shumei Kato, et al.
Cancer Research|May 23, 2002
Chromosome instability in lymphocytes: a potential indicator of predisposition to oral premalignant lesionsXifeng Wu, Scott M Lippman, J Jack Lee, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 28, 2004
A phase I trial of a Bcl-2 antisense (G3139) and weekly docetaxel in patients with advanced breast cancer and other solid tumorsJ Marshall, H Chen, D Yang, et al.
Oncogene|November 17, 2005
Oxidative metabolism of linoleic acid modulates PPAR-beta/delta suppression of PPAR-gamma activityX Zuo, Y Wu, J S Morris, et al.
Cancer Research|February 6, 2019
Novel Third-Generation EGFR Tyrosine Kinase Inhibitors and Strategies to Overcome Therapeutic Resistance in Lung CancerAyesha Murtuza, Ajaz Bulbul, John Paul Shen, et al.
Pageof 56

Showing results (231-240 of 551) with videos related to

Sort By:
Pageof 56
Gene|March 7, 2006
Identification and characterization of the human retinoid X receptor alpha gene promoterGuojun Li, Weihong Yin, Robert Chamberlain, et al.
Breast Cancer Research and Treatment|May 1, 1988
Comparison of monoclonal antibodies for the detection of occult breast carcinoma metastases in bone marrowA Thor, M J Viglione, N Ohuchi, et al.
Plos One|July 5, 2013
MicroRNA profiling of salivary adenoid cystic carcinoma: association of miR-17-92 upregulation with poor outcomeYoshitsugu Mitani, Dianna B Roberts, Hanadi Fatani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1983
Influence of tumor estrogen and progesterone receptor levels on the response to tamoxifen and chemotherapy in primary breast cancerB Fisher, C Redmond, A Brown, et al.
Cancer Research|February 5, 2013
MicroRNA-related genetic variants associated with clinical outcomes in early-stage non-small cell lung cancer patientsXia Pu, Jack A Roth, Michelle A T Hildebrandt, et al.
The Oncologist|September 19, 2020
Attrition of Patients on a Precision Oncology Trial: Analysis of the I-PREDICT ExperienceSandy S Bohan, Jason K Sicklick, Shumei Kato, et al.
Cancer Research|May 23, 2002
Chromosome instability in lymphocytes: a potential indicator of predisposition to oral premalignant lesionsXifeng Wu, Scott M Lippman, J Jack Lee, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 28, 2004
A phase I trial of a Bcl-2 antisense (G3139) and weekly docetaxel in patients with advanced breast cancer and other solid tumorsJ Marshall, H Chen, D Yang, et al.
Oncogene|November 17, 2005
Oxidative metabolism of linoleic acid modulates PPAR-beta/delta suppression of PPAR-gamma activityX Zuo, Y Wu, J S Morris, et al.
Cancer Research|February 6, 2019
Novel Third-Generation EGFR Tyrosine Kinase Inhibitors and Strategies to Overcome Therapeutic Resistance in Lung CancerAyesha Murtuza, Ajaz Bulbul, John Paul Shen, et al.
Pageof 56